PD6-2-4: Combined modality treatment for Malignant Pleural Mesothelioma (MPM)
نویسندگان
چکیده
منابع مشابه
Pleuropneumonectomy: an effective treatment modality for malignant pleural mesothelioma?
In Japan, asbestos was finally treated as a social issue in 2006, and a pleuropneumonectomy has been recently recognized as one of the effective treatments for malignant pleural mesothelioma. A pleuropneumonectomy for this disease was first performed by Wörn in 1974, followed by other reports made by Butchart et al., Rusch et al., and Sugarbaker et al. These reports include many problems, such ...
متن کاملPemetrexed plus carboplatin or cisplatin as neoadjuvant treatment of operable malignant pleural mesothelioma (MPM).
AIM The objective of this study was the retrospective evaluation of tolerability and activity of pemetrexed with carboplatin (AC) or cisplatin (AP) as neoadjuvant chemotherapy in a consecutive series of patients with malignant pleural mesothelioma (MPM). PATIENTS AND METHODS Patients with operable MPM received three cycles of AC or AP followed by surgery and radiotherapy. RESULTS Since 2005...
متن کاملDiagnosis and treatment of malignant pleural mesothelioma.
There are three major challenges in the diagnosis of malignant pleural mesothelioma: mesothelioma must be distinguished from benign mesothelial hyperplasia; malignant mesothelioma (and its subtypes) must be distinguished from metastatic carcinoma; and invasion of structures adjacent to the pleura must be demonstrated. The basis for clarifying the first two aspects is determination of a panel of...
متن کاملChimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM)
Cancer immunotherapy has now become a recognized approach to treating cancers. In addition to checkpoint blockade, adoptive T cell transfer (ACT) using chimeric antigen receptors (CARs) has shown impressive clinical outcomes in leukemias and is now being explored in solid tumors. CARs are engineered receptors, stably or transiently transduced into T cells, that aim to enhance T cell effector fu...
متن کاملDiagnosis and Treatment of Malignant Pleural Mesothelioma
There are three major challenges in the diagnosis of malignant pleural mesothelioma: mesothelioma must be distinguished from benign mesothelial hyperplasia; malignant mesothelioma (and its subtypes) must be distinguished from metastatic carcinoma; and invasion of structures adjacent to the pleura must be demonstrated. The basis for clarifying the first two aspects is determination of a panel of...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Thoracic Oncology
سال: 2007
ISSN: 1556-0864
DOI: 10.1097/01.jto.0000283334.13978.47